Posted by Two Blokes
PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing
Source: Two Blokes Trading
Posted by Two Blokes
Like many stocks, Brookfield Asset Management (BAM 1.03%) has slumped this year. Shares of the leading global
Source: Two Blokes Trading
Posted by Two Blokes
Shares of Netflix (NFLX 0.40%) soared to a record high after its first-quarter earnings report exceeded Wall S
Source: Two Blokes Trading
Posted by Two Blokes
Phase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than
Source: Two Blokes Trading
Posted by Two Blokes
Phase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than
Source: Two Blokes Trading
Posted by Two Blokes
First results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tu
Source: Two Blokes Trading
Posted by Two Blokes
First results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tu
Source: Two Blokes Trading
Posted by Two Blokes
Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted
Source: Two Blokes Trading
Posted by Two Blokes
NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical com
Source: Two Blokes Trading
Posted by Two Blokes
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohor
Source: Two Blokes Trading
Posted by Two Blokes
With the rise of artificial intelligence (AI) algorithms and a push for investment in domestic production and
Source: Two Blokes Trading
Posted by Two Blokes
Up until 2025, FuboTV (FUBO 1.17%) was something of an also-ran in the streaming wars. It was attempting to bu
Source: Two Blokes Trading